Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 225

    1.

    Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.

    Munier S, Delcroix-Genête D, Carthagéna L, Gumez A, Hazan U.

    Retrovirology. 2005 Nov 23;2:73.

    PMID:
    16305739
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.

    Quivy V, De Walque S, Van Lint C.

    Subcell Biochem. 2007;41:371-96. Review.

    PMID:
    17484137
    [PubMed - indexed for MEDLINE]
    4.

    Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.

    Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM.

    J Virol. 2003 Nov;77(21):11425-35.

    PMID:
    14557628
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.

    Van Lint C, Quivy V, Demonté D, Chariot A, Vanhulle C, de Walque S, Gaudray G, Veithen E, Bours V, Piette J, Burny A.

    Bull Mem Acad R Med Belg. 2004;159(Pt 2):176-89. Review.

    PMID:
    15615091
    [PubMed - indexed for MEDLINE]
    7.

    Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

    du Chéné I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia C, Mettling C, Baillat V, Reynes J, Corbeau P, Bertrand E, Marcello A, Emiliani S, Kiernan R, Benkirane M.

    EMBO J. 2007 Jan 24;26(2):424-35.

    PMID:
    17245432
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110.

    Liu Y, Li J, Kim BO, Pace BS, He JJ.

    J Biol Chem. 2002 Jun 28;277(26):23854-63. Epub 2002 Apr 16.

    PMID:
    11959860
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

    Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC.

    EMBO J. 2006 Jan 11;25(1):139-49. Epub 2005 Dec 1.

    PMID:
    16319923
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.

    Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):321-31.

    PMID:
    9833740
    [PubMed - indexed for MEDLINE]
    11.

    Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

    Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C.

    J Virol. 2002 Nov;76(21):11091-103.

    PMID:
    12368351
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.

    Marzio G, Tyagi M, Gutierrez MI, Giacca M.

    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13519-24.

    PMID:
    9811832
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR.

    Kashanchi F, Melpolder JC, Epstein JS, Sadaie MR.

    J Med Virol. 1997 Jun;52(2):179-89.

    PMID:
    9179766
    [PubMed - indexed for MEDLINE]
    15.

    Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

    Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C.

    PLoS One. 2009 Jun 30;4(6):e6093.

    PMID:
    19564922
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Dependence on host cell cycle for activation of human immunodeficiency virus type 1 gene expression from latency.

    Tobiume M, Fujinaga K, Kameoka M, Kimura T, Nakaya T, Yamada T, Ikuta K.

    J Gen Virol. 1998 Jun;79 ( Pt 6):1363-71.

    PMID:
    9634076
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

    Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.

    Leukemia. 2010 May;24(5):992-1000. Epub 2010 Mar 18.

    PMID:
    20237505
    [PubMed - indexed for MEDLINE]
    18.

    Cell line-dependent variability in HIV activation employing DNMT inhibitors.

    Fernandez G, Zeichner SL.

    Virol J. 2010 Oct 13;7:266.

    PMID:
    20942961
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.

    Laughlin MA, Zeichner S, Kolson D, Alwine JC, Seshamma T, Pomerantz RJ, Gonzalez-Scarano F.

    Virology. 1993 Oct;196(2):496-505.

    PMID:
    8372431
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk